triazolam has been researched along with Nephrotic Syndrome in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H | 1 |
| Haramoto, T | 1 |
| Sasaki, T | 1 |
| Hironaka, K | 1 |
| Shikata, K | 1 |
| Takahashi, K | 1 |
| Ota, Z | 1 |
1 other study available for triazolam and Nephrotic Syndrome
| Article | Year |
|---|---|
Massive eosinophilic infiltration in a patient with the nephrotic syndrome and drug-induced interstitial nephritis.
Topics: Eosinophilia; Eosinophils; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; M | 1995 |